Article | 3/3/2026

2025 Data Is In: Diagnostics Is Having a Renaissance

Medtech Strategist

By Wendy Diller, Contributors: Donna Hochberg and Gary Gustavsen

The diagnostic industry, a perpetual valuation laggard to higher-profile subsectors of the life sciences, with a short-lived exception during the height of COVID-19, may finally be having a moment. Reflecting this optimism, industry experts on a recent Arizona State University online seminar highlighted the success of a group of rising young and increasingly profitable tech-enabled diagnostics companies, labeling them the “Terrific 10,” a moniker that references the tech industry’s “Magnificent 7.”